Focus on vascular pharmacology

Doggrell S.A. (2004). Focus on vascular pharmacology. In: , , (543-552). .

Author Doggrell S.A.
Title of paper Focus on vascular pharmacology
Journal name Drug News and Perspectives   Check publisher's open access policy
Publication Year 2004
Sub-type Fully published paper
ISSN 0214-0934
Volume 17
Issue 8
Start page 543
End page 552
Total pages 10
Abstract/Summary At the joint meeting of the British Pharmacological Society and the Danish Society for Pharmacology and Toxicology, held July 6-8, 2004, in Bath, United Kingdom, the focus was vascular pharmacology. In the symposium on signaling pathways in vascular muscle, the topics included were the molecular structure of G-protein-coupled receptors, phosphoinositides and other lipid messengers, the regulation of vascular contractility by cyclic nucleotides, Ca2+ channels in the kidney vasculature, conducted vascular responses and intracellular signaling in smooth muscle cell growth. Endothelium-derived hyperpolarizing factor was the subject of a symposium and many of the communications. There was discussion whether epoxyeicosatrienoic acids, K +, C-type natriuretic peptide, hydrogen peroxide or gap junction were endothelium-derived hyperpolarizing factor. In the J.R. Vane Medal Lecture, Prof. P. Vanhoutte discussed endothelial dysfunction, and in the Anglo-Nordic Lecture, Prof. M. Mulvany discussed the pharmacology of hypertension. Finally, there was some discussion of whether antihypertensive drug response can be predicted on the basis of DNA microsequencing.
Subjects 3004 Pharmacology
Q-Index Code E1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: Scopus Import - Archived
 
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Tue, 05 Jul 2016, 11:58:33 EST by System User